Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Inhibition of the Transcription Factor RUNX1 Causes Glycosyltransferase a Repression

Romy Kronstein-Wiedemann, Laura Schmidt, Jörn Lausen, Erhard Seifried, MD PhD, Torsten Tonn, MD PhD

Blood (2017) 130 (Supplement 1): 925.

https://doi.org/10.1182/blood.V130.Suppl_1.925.925

Published: 2017

Journal Articles

Downregulation of Glycosyltransferase a Expression By miRNA-331-3p Is Mediated By the Inhibition of the Transcription Factor SP1

Romy Kronstein-Wiedemann, Peter Bugert, Erhard Seifried, MD PhD, Torsten Tonn, MD PhD

Blood (2016) 128 (22): 1247.

https://doi.org/10.1182/blood.V128.22.1247.1247

Published: 2016

Journal Articles

Mirna Regulation of Blood Group AB0 Genes

Romy Kronstein-Wiedemann, Dr., Paulina Nowakowska, Peter Milanov, Dr., Erhard Seifried, MD PhD, Torsten Tonn, MD PhD

Blood (2015) 126 (23): 158.

https://doi.org/10.1182/blood.V126.23.158.158

Published: 2015

Journal Articles

High Prevalence of Functional Laa Specific Cytotoxic T Lymphocytes in Healthy Individuals-Implications for Strategies in Adoptive T Cell Therapies of Relapsed Leukemia

Sarah Matko, Marcus Odendahl, PhD, Martin Bornhaeuser, MD, Torsten Tonn, MD PhD

Blood (2015) 126 (23): 5428.

https://doi.org/10.1182/blood.V126.23.5428.5428

Published: 2015

Journal Articles

Lowest numbers of primary CD8 + T cells can reconstitute protective immunity upon adoptive immunotherapy

Christian Stemberger, Patricia Graef, Marcus Odendahl, Julia Albrecht, Georg Dössinger, Florian Anderl, Veit R. Buchholz, Georg Gasteiger, Matthias Schiemann, Götz U. Grigoleit, Friedhelm R. Schuster, Arndt Borkhardt, Birgitta Versluys, Torsten Tonn, Erhard Seifried, Hermann Einsele, Lothar Germeroth, Dirk H. Busch, Michael Neuenhahn

Blood (2014) 124 (4): 628–637.

https://doi.org/10.1182/blood-2013-12-547349

Published: 2014

Includes: Supplemental data

Journal Articles

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Cornelia S. Link, MD, Elke Rücker-Braun, PhD, Sebastian Tuve, MD, Sarah Matko, Marc Schmitz, MD, Rebekka Wehner, PhD, Antje Tunger, Katja Sockel, MD, Stefani Parmentier, MD, Jan Moritz Middeke, MD, Änne Boldt, MD, Johannes Schetelig, MD, M. Sc,, Markus Odendahl, PhD, Torsten Tonn, MD, Martin Bornhäuser, MD, Falk Heidenreich, PhD

Blood (2013) 122 (21): 5488.

https://doi.org/10.1182/blood.V122.21.5488.5488

Published: 2013

Journal Articles

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice

Peter Milanov, Lacramioara Ivanciu, Daniela Abriss, Patricia Quade-Lyssy, Wolfgang Miesbach, Sonja Alesci, Torsten Tonn, Manuel Grez, Erhard Seifried, Jörg Schüttrumpf

Blood (2012) 119 (2): 602–611.

https://doi.org/10.1182/blood-2011-05-353672

Published: 2012

Journal Articles

Adoptive Transfer and Consequential Selective Reconstitution of Streptamer-Selected Cytomegalovirus-Specific CD8+ T Cells Leads to Enduring Virus Clearance in Patients after Allogeneic Stem Cell Transplantation

Anita Schmitt, Torsten Tonn, Dirk Busch, Götz Grigoleit, Hermann Einsele, Marcus Odendahl, Lothar Germeroth, Mark Ringhoffer, Simone Ringhoffer, Markus Wiesneth, Detlef Michel, Thomas Mertens, Markus Rojewski, Martin Marx, Stephanie Harsdorf, Hartmut Döhner, Erhard Seifried, Donald Bunjes, Michael Schmitt

Blood (2008) 112 (11): 1181.

https://doi.org/10.1182/blood.V112.11.1181.1181

Published: 2008

Journal Articles

CTL Responses Against Tumor Associated Antigens Are Part of the Graft Versus Leukemia-Effect and Protect from Relapse after Allogeneic Hematopoetic Stem Cell Transplantation.

Markus Kapp, Stefan Stevanovic, Kerstin Fick, Juergen Loeffler, Sen Mui Tan, Andreas Opitz, Torsten Tonn, Hermann Einsele, Goetz Ulrich Grigoleit

Blood (2007) 110 (11): 3231.

https://doi.org/10.1182/blood.V110.11.3231.3231

Published: 2007

Journal Articles

Streptamer Technology for the Assessment of CMVpp65 Specific CD8+ T Cell Frequencies and for the Adoptive T Cell Transfer to Post-Transplant Patients.

Anita Schmitt, MD, Junxia Yao, MD, Hermann Einsele, PhD, MD, Ulrich Grigoleit, MD, Dirk Busch, PhD, MD, Manuel Odendahl, MD, Lothar Germeroth, PhD, Torsten Tonn, PhD, MD, Markus Wiesneth, MD, Markus Rojewski, MD, Clemens Bechter, Stefanie von Harsdorf, MD, Hartmut Dohner, PhD, MD, Donald Bunjes, PhD, MD, Michael Schmitt, PhD, MD

Blood (2007) 110 (11): 1964.

https://doi.org/10.1182/blood.V110.11.1964.1964

Published: 2007

Journal Articles

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Jakob R. Passweg, MD, MS, Ulrike Koehl, PhD, Martin Stern, MD, Torsten Tonn, MD, Sandrine Meyer-Monard, MD, Peter Bader, MD, Johannes Rischewski, MD, Jan Soerensen, MD, Michael Paulussen, MD, Alois Gratwohl, MD, Thomas Klingebiel, MD, Andre Tichelli, MD, Dirk Schwabe, MD

Blood (2006) 108 (11): 411.

https://doi.org/10.1182/blood.V108.11.411.411

Published: 2006

Journal Articles

Re-Targeting of an NK Cell Line (NK92) with Specificity for CD19 Efficiently Kills Human B-Precursor Leukemia Cells.

Annette Romanski, Christoph Uherek, Gesine Bug, Tina Muller, Claudia Rossig, Manuela Kampfmann, Nicola Krossok, Dieter Hoelzer, Erhard Seifried, Winfried Wels, Oliver G. Ottmann, Torsten Tonn

Blood (2004) 104 (11): 2747.

https://doi.org/10.1182/blood.V104.11.2747.2747

Published: 2004

Journal Articles

Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction

Christoph Uherek, Torsten Tonn, Barbara Uherek, Sven Becker, Barbara Schnierle, Hans-Georg Klingemann, Winfried Wels

Blood (2002) 100 (4): 1265–1273.

https://doi.org/10.1182/blood.V100.4.1265.h81602001265_1265_1273

Published: 2002

NARROW

Inhibition of the Transcription Factor RUNX1 Causes Glycosyltransferase a Repression

Downregulation of Glycosyltransferase a Expression By miRNA-331-3p Is Mediated By the Inhibition of the Transcription Factor SP1

Mirna Regulation of Blood Group AB0 Genes

High Prevalence of Functional Laa Specific Cytotoxic T Lymphocytes in Healthy Individuals-Implications for Strategies in Adoptive T Cell Therapies of Relapsed Leukemia

Lowest numbers of primary CD8 + T cells can reconstitute protective immunity upon adoptive immunotherapy

Influence Of Steroid Exposure On CMV Specific T Cells Following Allogeneic Stem Cell Transplantation

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice

Adoptive Transfer and Consequential Selective Reconstitution of Streptamer-Selected Cytomegalovirus-Specific CD8+ T Cells Leads to Enduring Virus Clearance in Patients after Allogeneic Stem Cell Transplantation

CTL Responses Against Tumor Associated Antigens Are Part of the Graft Versus Leukemia-Effect and Protect from Relapse after Allogeneic Hematopoetic Stem Cell Transplantation.

Streptamer Technology for the Assessment of CMVpp65 Specific CD8+ T Cell Frequencies and for the Adoptive T Cell Transfer to Post-Transplant Patients.

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Re-Targeting of an NK Cell Line (NK92) with Specificity for CD19 Efficiently Kills Human B-Precursor Leukemia Cells.

Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only